Matinas BioPharma Holdings, Inc. announced the appointment of Jerome D. Jabbour, Co-founder and President of Matinas, as its Chief Executive Officer (CEO) and a member of its Board of Directors, effective immediately. As part of a planned transition, Roelof Rongen has stepped down as CEO and a member of the Board. Mr. Jabbour is a Co-founder of Matinas and has served as President since March 2016 and as Executive Vice President, Chief Business Officer since 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 USD | -1.61% | -4.62% | -23.68% |
05-09 | Transcript : Matinas BioPharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.68% | 42.06M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- MTNB Stock
- News Matinas BioPharma Holdings, Inc.
- Matinas BioPharma Announces Executive Changes